![\"54Gene's](\"https:\/\/x7d4c5z5.stackpathcdn.com\/wp-content\/uploads\/tc\/2020\/12\/54gene_novaseq6000_lab.jpg\")
54Gene’s genome sequencing lab is fitted with technology by Illumina, the American biotech. Image source: Abasi Ene-Obong on Twitter<\/p><\/div>\n
[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1617262337556{margin-top: 36px !important;}”]<\/p>\n
By\u00a0Oluwabukunmi Familoye<\/a>\u00a0and\u00a0Ikpeme Neto<\/a><\/em><\/p>\n [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n Nigeria doesn\u2019t contribute much to the global biotech industry which is\u00a0estimated<\/a>\u00a0to be worth $833.34 billion with a Compound Annual Growth Rate (CAGR) of over 7.02% by 2027,\u00a0 but this is beginning to change.<\/p>\n The impending growth of Biotech in Nigeria has been aided by the covid-19 pandemic where it has been central to the response. At the forefront of this increased attention is\u00a054gene<\/a>, a Nigerian biotech startup that has attracted $20 million in funding from Silicon Valley venture capitalists who are betting big on the yet unexplored African genome.<\/p>\n 54 gene\u2019s rise coinciding with the covid-19 pandemic has increased the potential for the founding of more biotech startups and an influx of more venture capital. Unlike other VC backed verticals, biotech is a highly specialized field that requires significant training, qualifications and expertise. Success here is predicated on the difficult ability to develop and commercialize research findings from the laboratory bench.<\/p>\n The Laboratory Bench<\/strong>\u00a0and the Role of Government<\/strong><\/p>\n In 2001, Nigeria approved a National biotechnology policy that led to the establishment of the National Biotechnology Development Agency (NABDA) under the aegis of the Federal Ministry of science and technology. The agency\u2019s goal is to \u201cpromote, coordinate and set the research and development priority in biotechnology for Nigeria.<\/p>\n To further its mission, NABDA established twenty-five (25) bioresources centres in remote areas in Nigeria intending to discover untapped resources for biotech research and development. Between the parent agency and these centres, there isn\u2019t much discernable research output. While the agency\u2019s website alludes to being at the \u201ccutting edge for the socio-economic wellbeing of the nation\u201d, the filler \u2018lorem ipsum\u2019 text still on the agency\u2019s website calls into question the commitment to their mission. The agency has also not been helped by its chronic underfunding and graft from its leadership. Its 2021 budget is only $8 million while its acting director-general was in 2020\u00a0arrested<\/a>\u00a0for allegedly misappropriating about $1 million further impairing the prospects of the agency.<\/p>\n A government agency on the other hand that has had significant research output is the\u00a0Nigerian Institute Of Medical Research<\/a>\u00a0(NIMR) in Yaba, Lagos. Established in 1977, the institute has played a relatively active role in health research in Nigeria. It has a track record of research and collaboration. Prior to the COVID-19 pandemic, they\u00a0collaborated with CCHUB<\/a>\u00a0to develop a digital tool to aid adherence to Tuberculosis medications. In 2019, its partnership with the Institute of Pasteur Senegal enabled them to acquire more skills in the detection of viruses using serological assays. This increased its preparedness for the COVID-19 pandemic when it struck in Nigeria in 2020.<\/p>\n [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_btn title=”Read Full Article” style=”outline” color=”juicy-pink” align=”center” button_block=”true” link=”url:https%3A%2F%2Ftechcabal.com%2F2021%2F03%2F31%2Fnigeria-54gene-covid-19-biotechnology%2F||target:%20_blank|rel:nofollow”][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":" [vc_row][vc_column][vc_column_text css=”.vc_custom_1617262218000{margin-top: 36px !important;}”] 54Gene, COVID-19 and the prospects of [\u2026]<\/span><\/p>\n","protected":false},"author":2,"featured_media":10166,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","footnotes":""},"categories":[28],"tags":[175],"class_list":["post-10164","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-175"],"_links":{"self":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/posts\/10164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/comments?post=10164"}],"version-history":[{"count":3,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/posts\/10164\/revisions"}],"predecessor-version":[{"id":10168,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/posts\/10164\/revisions\/10168"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/media\/10166"}],"wp:attachment":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/media?parent=10164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/categories?post=10164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/tags?post=10164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}